• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Biogen Inc

Recent news which mentions Biogen Inc

< Previous 1 2 3 4 Next >
Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug
August 07, 2023
Tags Regulations Business US: News
From CNBC.com News
Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more
July 28, 2023
Tags First Solar Inc Enphase Energy Inc Pfizer Inc
From CNBC.com News
Stocks making the biggest moves midday: Spotify, RTX, General Electric and more
July 25, 2023
Tags NXP Semiconductors NV United Parcel Service Inc Zscaler Inc
From CNBC.com News
Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
July 25, 2023
Tags Biotechnology Biogen Inc Biotech and Pharmaceuticals
From CNBC.com News
5 things to know before the stock market opens Tuesday
July 18, 2023
Tags Morgan Stanley Tesla Inc Citigroup Inc
From CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
July 17, 2023
Tags Eisai Co Ltd Business News Alzheimer's disease
From CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
July 08, 2023
Tags U/S/ Economy Science Social issues
From CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
July 07, 2023
Tags Biogen Inc Biotechnology Biotech and Pharmaceuticals
From CNBC.com News
Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more
July 07, 2023
Tags Business Economy Meta Platforms Inc
From CNBC.com News
Stocks making the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more
July 07, 2023
Tags Stock markets Levi Strauss & Co Breaking News: Markets
From CNBC.com News
Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug
July 07, 2023
Tags Eisai Co Ltd Pharmaceuticals Social issues
From CNBC.com News
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
July 06, 2023
Tags Eisai Co Ltd Business News Breaking News: Business
From CNBC.com News
Stocks making the biggest moves midday: JD.Com, Biogen, Oracle and more
June 13, 2023
Tags Devon Energy Corp Transocean Ltd Carnival Corp
From CNBC.com News
FDA advisors to weigh whether Alzheimer's drug Leqembi should receive full approval
June 09, 2023
Tags US: News US Economy Business
From CNBC.com News
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
June 07, 2023
Tags Biogen Inc Biotechnology Biotech and Pharmaceuticals
From CNBC.com News
Jim Cramer expects defensive stocks to be resilient as debt ceiling talks drag on
May 15, 2023
Tags Stock Picks Food and Beverage Business News
From CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
May 12, 2023
Tags Policy Health care industry Health & Science
From CNBC.com News
Stocks making the biggest moves premarket: Starbucks, AMD, Pearson, PacWest & more
May 03, 2023
Tags Finance PacWest Bancorp Advanced Micro Devices Inc
From CNBC.com News
Bipartisan attorneys general call on Medicare to cover Alzheimer's treatments
May 01, 2023
Tags Pandemics Epidemics U/S/ Economy
From CNBC.com News
Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease
April 30, 2023
Tags Breaking News: Business Business News Business
From CNBC.com News
Alzheimer's: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says
April 26, 2023
Tags Health care industry Policy Health & Science
From CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
April 25, 2023
Tags Health care industry Health & Science Companies
From CNBC.com News
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease
April 25, 2023
Tags Science Breaking news Health & Science
From CNBC.com News
Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says
April 06, 2023
Tags Science Breaking news Companies
From CNBC.com News
Eli Lilly says experimental Alzheimer's drug reduces brain plaque in early study
April 05, 2023
Tags Breaking News: Business Eisai Co Ltd Eli Lilly and Co
From CNBC.com News
FDA advisors reject Biogen's ALS drug for rare and aggressive form of the disease
March 22, 2023
Tags Breaking news Biogen Inc Biotechnology
From CNBC.com News
FDA staff says Biogen's ALS drug may have a 'clinical benefit' on a rare form of the disease
March 20, 2023
Tags Health & Science Health care industry Pharmaceuticals
From CNBC.com News
Veterans' Health will cover Alzheimer's treatment Leqembi for some patients
March 13, 2023
Tags Pandemics Epidemics U/S/ Economy
From CNBC.com News
FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July
March 06, 2023
Tags Pandemics Epidemics U/S/ Economy
From CNBC.com News
Medicare rejects Alzheimer's Association request for unrestricted coverage of treatments like Leqembi
February 23, 2023
Tags Biotechnology Biogen Inc Biotech and Pharmaceuticals
From CNBC.com News
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap